Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will participate at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback